Position in AUTL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,175,520
+$2,212 QoQ
Shares Held
1,984,700
-13.7% QoQ
Ownership
0.746%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 84 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AUTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,579,858 across 312 Biotechnology names. AUTL ranks #102 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in AUTL
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,175,520 | 1,984,700 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,173,308 | 2,299,499 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,179,753 | 3,105,404 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $7,956,636 | 4,881,372 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,992,736 | 1,751,200 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,455,393 | 1,584,125 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,454,513 | 618,942 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $910,661 | 250,871 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,984,794 | 1,145,056 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,066,482 | 323,900 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,027,824 | 159,600 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $637,672 | 273,679 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $359,856 | 151,200 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $199,456 | 108,400 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $87,970 | 46,300 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $53,928 | 25,200 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $36,224 | 12,800 | Shares | Sole | 2022-08-12 | |
| 2021-03-31 | $467,499 | 81,588 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $723,746 | 80,956 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $624,555 | 53,656 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,160,572 | 72,400 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $961,371 | 160,496 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||